BioSpace · 1 week ago
Associate Director, Machine Learning
Wonder how qualified you are to the job?
BiotechnologyCommunities
Comp. & Benefits
Insider Connection @BioSpace
Responsibilities
Design and perform analyses to infer causal mechanisms driving inflammatory mechanisms integrating data collected from pre-clinical models and human data sets.
Drive implementation of predictive models combining clinical, genetic, imaging, and circulating biomarkers to illuminate biological mechanisms and enable patient stratification and indication expansion.
Participate in and oversight of scientific report writing.Presentation of methods, results, and conclusions to a publishable standard.
Communicate findings in multiple settings (including 1:1, group and project meetings).
Strong at building partnerships and working collaboratively with others to meet shared objectives.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
PhD in Computer Science (concentration on machine learning/AI), Engineering, Statistics, or a related field
Minimum of 7 years of relevant biotech and/or pharmaceutical industry experience preferred
Proficiency with at least one high-level programming language (R, Python, C/C++) for complex data analysis and reproducible research practices
Experience analyzing high-dimensional molecular data, such as imaging, video, or transcriptomics
Experience leading a team of machine learning scientists to deliver on predefined key corporate objectives
Preferred
Background in inflammatory diseases (e.g., autoimmune diseases, IBD, and scleroderma) and/or experience working with clinical trial data is a plus
Benefits
Bonus
Equity
Comprehensive Benefits
Company
BioSpace
BioSpace is the leading online community for industry news and careers for life science professionals.
Funding
Current Stage
Growth StageTotal Funding
$10M2000-08-24Series B· $10M
Recent News
2024-05-31
2024-05-05
2024-04-06
Company data provided by crunchbase